City

Clinical trials near Jacksonville, United States

Active studies with a listed research site in Jacksonville, United States.

23active studies

9recruiting now

5countries represented

74largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 3

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Obesity, OverweightCondition

aleniglipron, aleniglipronTreatment

United States74 locations

Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure TherapeuticsSponsor

Updated 2026-09-01 · NCT07654374See eligibility →

Recruiting nowPhase 4

The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity

Obesity, Menopause Hot FlashesCondition

Tirzepatide, PlaceboTreatment

United States1 locations

Mayo ClinicSponsor

Updated 2026-08-18 · NCT07218445See eligibility →

Recruiting nowPhase 2

A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)

Overweight, ObesityCondition

PF-08653945, PF-08653944Treatment

Canada, United States65 locations

PfizerSponsor

Updated 2026-08-17 · NCT07575932See eligibility →

Recruiting nowPhase 2

Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder

Opioid Use Disorder, Opioid Use Disorder, ModerateCondition

Tirzepatide, PlaceboTreatment

United States9 locations

T. John Winhusen, PhDSponsor

Updated 2026-08-11 · NCT06651177See eligibility →

Recruiting nowPhase 2

Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Related Comorbidity

Obesity, OverweightCondition

KAI-7535, PlaceboTreatment

Australia, United States36 locations

KaileraSponsor

Updated 2026-07-28 · NCT07497880See eligibility →

Recruiting nowPhase 1

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

Obesity, OverweightCondition

Cagrilintide, Placebo (matched to Cagrilintide)Treatment

United States11 locations

Novo Nordisk A/SSponsor

Updated 2026-06-25 · NCT07607587See eligibility →

Recruiting nowPhase 1

Single and Multiple Ascending Dose Study of AMG 513 in Participants With Obesity

Cardiometabolic DiseaseCondition

AMG 513, PlaceboTreatment

United States10 locations

AmgenSponsor

Updated 2026-06-22 · NCT06585462See eligibility →

Recruiting nowPhase 4

Knee Injections for Obese Patients With Knee Arthritis

Osteoarthritis of KneeCondition

Triamcinolone Acetonide Low Dose, Triamcinolone Acetonide Standard DoseTreatment

United States1 locations

Mayo ClinicSponsor

Updated 2026-03-10 · NCT06782529See eligibility →

Recruiting nowNot applicable

Effects of Glucagon-like Peptide-1 (GLP-1) Agonist in Neuro-reproductive Function in Obese Adolescent Females With Polycystic Ovary Syndrome (PCOS)

Polycystic Ovarian Syndrome in Adolescent Females, Obesity (Disorder)Condition

GLP-1 Receptor AgonistsTreatment

United States1 locations

Nemours Children's ClinicSponsor

Updated 2025-09-16 · NCT07169136See eligibility →

Opening soonPhase 3

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Overweight, ObesityCondition

Zenagamtide, SemaglutideTreatment

United States43 locations

Novo Nordisk A/SSponsor

Updated 2026-08-25 · NCT07668414See eligibility →

Opening soonPhase 3

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Overweight, ObesityCondition

zenagamtide, PlaceboTreatment

United States37 locations

Novo Nordisk A/SSponsor

Updated 2026-08-25 · NCT07720271See eligibility →

Opening soonPhase 4

Semaglutide and Structured Lifestyle Support to Improve Heart and Blood Vessel Health in Postmenopausal Obese Breast Cancer Survivors Taking Aromatase Inhibitors

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8Condition

Biospecimen Collection, Dual X-ray AbsorptiometryTreatment

United States1 locations

Mayo ClinicSponsor

Updated 2026-08-17 · NCT07769047See eligibility →

Opening soonPhase 2

Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese

Obesity and OverweightCondition

NA-931, TirzepatideTreatment

Australia, New Zealand17 locations

Biomed Industries, Inc.Sponsor

Updated 2026-03-27 · NCT06732245See eligibility →

Invitation onlyPhase 4

Aging Well: Targeting Obesity With GLP-1 Agonists to Enhance Physical and Vascular Health in Postmenopausal Women

Obesity, MenopauseCondition

semaglutide or tirzepatide, Lifestyle modification interventionTreatment

United States1 locations

Mayo ClinicSponsor

Updated 2026-07-20 · NCT07057310See eligibility →

Invitation onlyNot applicable

Dietary Sugar Absorptive Phenotype for Prediction of Weight Loss Outcome

Obese, HealthyCondition

Endoscopic biopsyTreatment

United States1 locations

Mayo ClinicSponsor

Updated 2025-09-10 · NCT05408728See eligibility →

Active, not recruitingPhase 2

A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation

ObesityCondition

Trevogrumab-Part A, Trevogrumab-Part B and Part CTreatment

Puerto Rico, United States60 locations

Regeneron PharmaceuticalsSponsor

Updated 2026-09-01 · NCT06299098See eligibility →

Active, not recruitingPhase 2

Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)

Overweight, Type 2 DiabetesCondition

Petrelintide, PlaceboTreatment

United States48 locations

Zealand PharmaSponsor

Updated 2026-08-21 · NCT06926842See eligibility →

Active, not recruitingPhase 3

A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-term

ObesityCondition

CagriSema (Cagrilintide B and Semaglutide I), Placebo matched to CagriSema (Cagrilintide B and Semaglutide I)Treatment

United States46 locations

Novo Nordisk A/SSponsor

Updated 2026-07-24 · NCT07011667See eligibility →

Active, not recruitingPhase 4

A Study of a Novel Precision Medicine Approach For Obesity

ObesityCondition

Semaglutide, PlaceboTreatment

United States2 locations

Mayo ClinicSponsor

Updated 2026-07-16 · NCT06814938See eligibility →

Active, not recruitingPhase 2

A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight

Obesity, OverweightCondition

Bimagrumab, TirzepatideTreatment

United States12 locations

Eli Lilly and CompanySponsor

Updated 2026-05-26 · NCT06643728See eligibility →

Active, not recruitingPhase 2

Study to Explore the Safety and Efficacy of NT-0796 as an Adjunct to Semaglutide in Participants With Obesity (RESOLVE-2)

ObesityCondition

NT-0796, PlaceboTreatment

United States9 locations

NodThera LimitedSponsor

Updated 2026-04-08 · NCT07220629See eligibility →

Active, not recruitingNot applicable

Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15% Weight Loss on Tirzepatide

Obesity, Weight Change TrajectoryCondition

Revita Duodenal Mucosal Resurfacing (DMR), ShamTreatment

United States32 locations

Fractyl Health Inc.Sponsor

Updated 2026-03-03 · NCT06484114See eligibility →

Active, not recruitingPhase 2

Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor Agonist

Endocrinology, Diabetes, Type IICondition

AZD6234, Placebo to matchTreatment

United States18 locations

AstraZenecaSponsor

Updated 2026-03-03 · NCT06851858See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.

Clinical trials near Jacksonville, United States

Current studies

Related cities